Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.07 | 0.7 |
mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |